The importance of biochemical indicators in determining male infertility
DOI:
https://doi.org/10.15584/ejcem.2024.3.16Keywords:
FSH, LH, male infertility, prolactin and fructoseAbstract
Introduction and aim. Recently, infertility has become a global problem and the frequency of the “male” factor in family infertility has reached 40-50%. The aim of the research is to investigate the role of some biochemical indicators (endocrine factors and fructose) in determining male infertility.
Material and methods. In the study, the spermogram of 101 men aged 20–46 with idiopathic male infertility, the concentration of follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin and testosterone hormones in their blood, and the concentration of fructose in their sperm samples were analyzed, and their correlations were determined.
Results. The concentration of FSH in the blood serum of men with asthenozoospermia and oligozoospermia increased statistically significantly by 57.7% and 2.4 times, respectively, compared to the control. More serious endocrinological disorders were recorded in men with azoospermia. In men with non-obstructive azoospermia, the concentration of FSH is 8.8 times, that of LH is 2.9 times; while prolactin increased by 89.0% compared to the control, testosterone concentration decreased by 22.9%. The fructose concentration in the oligozoospermia group compared to the control group increased by 60.8% (pH1<0.001), and in the non-obstructive azoospermia group by 2.0 times (pH1=0.001). A positive correlation between FSH and LH and a negative correlation between fructose concentration and forward motility of spermatozoa were determined in both asthenospermic and oligozoospermic patients (ρ=0.544; p=0.002). In case of non-obstructive azoospermia, FSH and prolactin, in azoospermia, LH and testosterone were directly proportional.
Conclusion. During male infertility, there is a serious relationship between sperm indicators and endocrine disorders. An increase in the concentration of fructose is the main indicator of a decrease in the number and motility of spermatozoa. A high concentration of FSH and LH in men with azoospermia can be considered one of the important indicators in the diagnosis of non-obstructive azoospermia.
Downloads
References
Toragall MM, Satapathy SK, Kadadevaru GG, Hiremath MB. Evaluation of Seminal Fructose and Citric Acid Levels in Men with Fertility Problem. J Hum Reprod Sci. 2019;12(3):199-203. doi: 10.4103/jhrs.JHRS_155_18
Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reprod Biol Endocrinol. 2015;13:37. doi: 10.1186/s12958-015-0032-1
Gangwar PK, Sankhwar SN, Pant S, et al. Increased Gonadotropins and prolactin are linked to infertility in males. Bioinformation. 2020;16(2):176-182. doi: 10.6026/97320630016176
Gamidov SI, Ovchinnikov RI, Popova AYu, Naumov NP, Gasanov NG. Role of male infertility in assisted reproductive technology programs (a literature review). Andrology and Genital Surgery. 2017;18(3):28-36. doi: 10.17650/2070-9781-2017-18-3-28-36
Nguyen HTT, Dang HNT, Nguyen TTT, et al. Correlations between abnormalities of morphological details and DNA fragmentation in human sperm. Clin Exp Reprod Med. 2022;49(1):40-48. doi: 10.5653/cerm.2021.04777
Pavlov DS, Zubkova AYu, Kamaeva IA, Guskova EN. Spermogram as one of the most important laboratory methods for studying male fertility. Young Scientist. 2016;26.2(130.2):30-34.
World Health Organization. Laboratory manual for the examination and processing of human semen. 5th ed. Geneva: World Health Organization; 2010.
Moretti E, Signorini C, Noto D, Corsaro R, Collodel G. The relevance of sperm morphology in male infertility. Front Reprod Health. 2022;4:945351. doi: 10.3389/frph.2022.945351
Okonofua FE, Ntoimo LFC, Omonkhua A, et al. Causes and Risk Factors for Male Infertility: A Scoping Review of Published Studies. Int J Gen Med. 2022;15:5985-5997. doi: 10.2147/IJGM.S363959
Agarwal A, Majzoub A, Parekh N, Henkel R. A schematic overview of the current status of male infertility practice. World J Mens Health. 2020;38:308-322. doi: 10.5534/wjmh.190068
Murgia F, Corda V, Serrenti M, et al. Seminal Fluid Metabolomic Markers of Oligozoospermic Infertility in Humans. Metabolites. 2020;10(2):64. doi: 10.3390/metabo10020064
Sengupta P, Dutta S, Karkada IR, Chinni SV. Endocrinopathies and Male Infertility. Life (Basel). 2021;12(1):10. doi: 10.3390/life12010010
Babakhanzadeh E, Nazari M, Ghasemifar S, Khodadadian A. Some of the Factors Involved in Male Infertility: A Prospective Review. Int J Gen Med. 2020;13:29-41. doi: 10.2147/IJGM.S241099.
Li X, Zhu Q, Wen Z, et al. Androgen and Luteinizing Hormone Stimulate the Function of Rat Immature Leydig Cells Through Different Transcription Signals. Front. Endocrinol. 2021;12:599149. doi: 10.3389/fendo.2021.599149.
de Mattos K, Pierre KJ, Tremblay JJ. Hormones and Signaling Pathways Involved in the Stimulation of Leydig Cell Steroidogenesis. Endocrines. 2023;4:573-594. doi: 10.3390/ endocrines4030041
Corinne TM, Anatole PC, Jeanne NY. Comparison of Serum Inhibin B and Follicle-Stimulating Hormone (FSH) Level between Normal and Infertile Men in Yaoundé. International Journal of Reproductive Medicine. 2020;2020:4765809.
Grande G, Barrachina F, Soler-Ventura A, et al. The Role of Testosterone in Spermatogenesis: Lessons From Proteome Profiling of Human Spermatozoa in Testosterone Deficiency. Front. Endocrinol. 2022:13:852661. doi: 10.3389/fendo.2022.852661
Shirshov V.N. Current state of the male infertility problem: the review of european association of urology clinical guidelines. Clinical Practice. 2016;1(25):39-50.
Tsujii H, Ohta E, Miah AG, Hossain Sh. Effect of fructose on motility, acrosome reaction and in vitro fertilization capability of boar spermatozoa. Reprodactive Medicine Biology. 2006;5(4):255-261. doi: 10.1111/j.1447-0578.2006.00150.x
Barak S, Baker HWG. Clinical Management of Male Infertility. 2016; Feb 5. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.
Wald G, Punjani N, Hayden R, Feliciano M, Dudley V, Goldstein M. Assessing the clinical value of the Kruger strict morphology criteria over the World Health Organization fourth edition criteria. FS Rep. 2021;2(2):176-180. doi: 10.1016/j.xfre.2021.04.003
Gangwar PK, Sankhwar SN, Pant S, et al. Increased Gonadotropins and prolactin are linked to infertility in males. Bioinformation. 2020;16(2):176-182. doi: 10.6026/97320630016176
Al-Daghistani H, Abdel-Dayem M. Hyperprolactinemia And Hypergo¬nadotropins In Infertile Males With Sever Oligospermia And Azoospermia. The Internet Journal of Endocrinology. 2006;3(1):1-6.
Hadeel AI, Zhian SR. Impact of Serum Prolactin and Testosterone Levels on Male Infertility in Sulaimanyah City. Mosul Journal of Nursing. 2021;7(9):207-214. doi: 10.33899/mjn.2021.168676
Palani K, Abdul Jabbar A, Jagannathan N. Babu TT. Association of serum hormone profile and semen quality of infertile males in and around Chennai. Int J Reprod Contracept Obstet Gynecol. 2020;9(12):4860-4869. doi: https://doi.org/10.18203/2320-1770.ijrcog20204935
Bradley DA. Approach to Male Infertility and Induction of Spermatogenesis. The Journal of Clinical Endocrinology & Metabolism. 2013;98(9):3532-3542. doi: 10.1210/jc.2012-2400
Oduwole OO, Peltoketo H, Huhtaniemi IT. Role of Follicle-Stimulating Hormone in Spermatogenesis. Front Endocrinol. 2018;14(9):763. doi: 10.3389/fendo.2018.00763
Raut S., Deshpande S., Balasinor NH. Unveiling the Role of Prolactin and its Receptor in Male Reproduction. Horm Metab Res. 2019;51:215-219. doi: 10.1055/a-0859-1144
Ndovi TT, Choi L, Caffo B, et al. Quantitative assessment of seminal vesicle and prostate drug concentrations by use of a noninvasive method. Clin Pharmacol Ther. 2006;80(2):146-158. doi: 10.1016/j.clpt.2006.04.013
Agarwal A, Sharma RK, Gupta S. et al. Sperm Vitality and Necrozoospermia: Diagnosis, Management, and Results of a Global Survey of Clinical Practice. World J Mens Health. 2022;40(2):228-242. doi: 10.5534/wjmh.210149
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
